UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.335

Sortiert nach

Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis

Arteriosclerosis, thrombosis, and vascular biology, 2002-05, Vol.22 (5), p.717

2002

Link zum Volltext

Verfügbarkeit prüfen

Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation

Inflammation research, 2000-10, Vol.49 (10), p.497-505

2000

Link zum Volltext

Verfügbarkeit prüfen

Peroxisome proliferator-activated receptors in inflammation control

Journal of endocrinology, 2001-06, Vol.169 (3), p.453-459

2001

Link zum Volltext

Verfügbarkeit prüfen

Human Plasma Lipoproteins

1, 2019

Link zum Volltext

Verfügbarkeit prüfen

An Apolipoprotein Influencing Triglycerides in Humans and Mice Revealed by Comparative Sequencing

Science (American Association for the Advancement of Science), 2001-10, Vol.294 (5540), p.169-173

2001

Link zum Volltext

Verfügbarkeit prüfen

FDG-PET–driven consolidation strategy in diffuse large B-cell lymphoma: final results of a randomized phase 2 study

Blood, 2017-09, Vol.130 (11), p.1315-1326

2017

Link zum Volltext

Verfügbarkeit prüfen

Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients

Leukemia, 2014-03, Vol.28 (3), p.675-679

2014

Link zum Volltext

Verfügbarkeit prüfen

Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPARα, PPARγ, and LXR

Biochemical and biophysical research communications, 2004-01, Vol.314 (1), p.151-158

2004

Link zum Volltext

Verfügbarkeit prüfen

Peroxisome Proliferator-Activated Receptor α Reduces Cholesterol Esterification in Macrophages

Circulation research, 2003-02, Vol.92 (2), p.212-217

2003

Link zum Volltext

Verfügbarkeit prüfen

Liver X Receptor Activation Controls Intracellular Cholesterol Trafficking and Esterification in Human Macrophages

Circulation research, 2005-09, Vol.97 (7), p.682-689

2005

Link zum Volltext

Verfügbarkeit prüfen

Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators

Nature (London), 1998-06, Vol.393 (6687), p.790-793

1998

Link zum Volltext

Verfügbarkeit prüfen

Hypodiploidy is a major prognostic factor in multiple myeloma

Blood, 2001-10, Vol.98 (7), p.2229-2238

2001

Link zum Volltext

Verfügbarkeit prüfen

PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway

Nature medicine, 2001-01, Vol.7 (1), p.53-58

2001

Link zum Volltext

Verfügbarkeit prüfen

Peroxisome proliferator-activated receptors and inflammation: from basic science to clinical applications

International Journal of Obesity, 2003-12, Vol.27 (3), p.S41-S45

2003

Link zum Volltext

Verfügbarkeit prüfen

Cigarette smoking is associated with unhealthy patterns of nutrient intake: a meta-analysis

The Journal of nutrition, 1998-09, Vol.128 (9), p.1450-1457

1998

Link zum Volltext

Verfügbarkeit prüfen

Induction of IκBα Expression as a Mechanism Contributing to the Anti-inflammatory Activities of Peroxisome Proliferator-activated Receptor-α Activators

The Journal of biological chemistry, 2000-11, Vol.275 (47), p.36703-36707

2000

Link zum Volltext

Verfügbarkeit prüfen

An update on the mechanisms of action of the peroxisome proliferator-activated receptors (PPARs) and their roles in inflammation and cancer

Cellular and molecular life sciences : CMLS, 1999-06, Vol.55 (6-7), p.932-943

1999

Link zum Volltext

Verfügbarkeit prüfen

Alteration of the in vivo nicotinic receptor density in ADNFLE patients: a PET study

Brain (London, England : 1878), 2006-08, Vol.129 (8), p.2047-2060

2006

Link zum Volltext

Verfügbarkeit prüfen

Peroxisome Proliferator-Activated Receptor Activators Inhibit Thrombin-Induced Endothelin-1 Production in Human Vascular Endothelial Cells by Inhibiting the Activator Protein-1 Signaling Pathway

Circulation research, 1999-09, Vol.85 (5), p.394-402

1999

Link zum Volltext

Verfügbarkeit prüfen

PI3K inhibition and modulation of immune and tumor microenvironment markers by copanlisib in patients with non-Hodgkin's lymphoma or advanced solid tumors

Annals of oncology, 2018-10, Vol.29, p.viii20-viii20

2018

Link zum Volltext

Verfügbarkeit prüfen

LONG‐TERM OUTCOMES OF ELDERLY PATIENTS TREATED WITH FRONTLINE R‐CHOP: UPDATE OF THE LNH03‐6B TRIAL

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Link zum Volltext

Verfügbarkeit prüfen

Lymphoma occurring in patients over 90 years of age: characteristics, outcomes, and prognostic factors. A retrospective analysis of 234 cases from the LYSA

Annals of oncology, 2013-10, Vol.24 (10), p.2612-2618

2013

Link zum Volltext

Verfügbarkeit prüfen

Long-term follow-up of high-dose treatment with autologous haematopoietic progenitor cell support in 693 patients with follicular lymphoma: an EBMT registry study

Leukemia, 2007-11, Vol.21 (11), p.2324-2331

2007

Link zum Volltext

Verfügbarkeit prüfen

Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B)

Annals of oncology, 2013-04, Vol.24 (4), p.1032-1037

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.335

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.065)
Mit Volltextzugriff
(1.050)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.031)
Französisch
(295)
Japanisch
(150)
Deutsch
(9)
Russisch
(3)
Polnisch
(1)

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(641)
Science & Technology
(635)
Life Sciences & Biomedicine
(525)
Biological And Medical Sciences
(308)
Male
(295)
Animals
(250)
Medical Sciences
(215)
Female
(200)
Adult
(179)
Middle Aged
(170)
Biochemistry & Molecular Biology
(169)
Lipoproteins - Blood
(124)
Cardiovascular System & Cardiology
(112)
Mice
(112)
Physics
(105)
Triglycerides - Blood
(103)
Physical Sciences
(97)
Fundamental And Applied Biological Sciences. Psychology
(96)
Peripheral Vascular Disease
(96)
Atherosclerosis
(90)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis

Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation

Peroxisome proliferator-activated receptors in inflammation control

Human Plasma Lipoproteins

An Apolipoprotein Influencing Triglycerides in Humans and Mice Revealed by Comparative Sequencing

FDG-PET–driven consolidation strategy in diffuse large B-cell lymphoma: final results of a randomized phase 2 study

Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients

Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPARα, PPARγ, and LXR

Peroxisome Proliferator-Activated Receptor α Reduces Cholesterol Esterification in Macrophages

Liver X Receptor Activation Controls Intracellular Cholesterol Trafficking and Esterification in Human Macrophages

Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators

Hypodiploidy is a major prognostic factor in multiple myeloma

PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway

Peroxisome proliferator-activated receptors and inflammation: from basic science to clinical applications

Impact of the use of autologous stem cell transplantation at first relapse both in naïve and previously rituximab exposed follicular lymphoma patients treated in the GELA/GOELAMS FL2000 study

Cigarette smoking is associated with unhealthy patterns of nutrient intake: a meta-analysis

Induction of IκBα Expression as a Mechanism Contributing to the Anti-inflammatory Activities of Peroxisome Proliferator-activated Receptor-α Activators

An update on the mechanisms of action of the peroxisome proliferator-activated receptors (PPARs) and their roles in inflammation and cancer

Alteration of the in vivo nicotinic receptor density in ADNFLE patients: a PET study

Peroxisome Proliferator-Activated Receptor Activators Inhibit Thrombin-Induced Endothelin-1 Production in Human Vascular Endothelial Cells by Inhibiting the Activator Protein-1 Signaling Pathway

PI3K inhibition and modulation of immune and tumor microenvironment markers by copanlisib in patients with non-Hodgkin's lymphoma or advanced solid tumors

LONG‐TERM OUTCOMES OF ELDERLY PATIENTS TREATED WITH FRONTLINE R‐CHOP: UPDATE OF THE LNH03‐6B TRIAL

Lymphoma occurring in patients over 90 years of age: characteristics, outcomes, and prognostic factors. A retrospective analysis of 234 cases from the LYSA

Long-term follow-up of high-dose treatment with autologous haematopoietic progenitor cell support in 693 patients with follicular lymphoma: an EBMT registry study

Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B)

Suchergebnisse filtern